TRPV1 and central nervous system cancer: Upon exposure to low doses of the TRPV1 specific agonist capsaicin (CPS), the TRPV1-Ca2+ may sustain apoptosis in gliomas through the selective activation of p38 MAPK, but not ERK MAPK (Amantini et al., 2007).